Cytoprotective effect of rabeprazole against ethanol-induced gastric mucosal damage: Possible involvement of nitric oxide

Drugs under Experimental and Clinical Research

Volumn 26, Issue 2, 2000, Pages 41-45

  Watanabe, Toshio ^a   Higuchi, K ^a   Tominaga, K ^a   Fujiwara, Y ^a   Arakawa, T ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ARGININE; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROSTAGLANDIN; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; MALE; NONHUMAN; RAT; STOMACH INJURY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; BENZIMIDAZOLES; ENZYME INHIBITORS; GASTRIC MUCOSA; INDOMETHACIN; INJECTIONS, INTRAPERITONEAL; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEPRAZOLE; PROSTAGLANDINS; RATS; RATS, WISTAR; STOMACH ULCER;

EID: 0034121866     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Sachs G. Proton pump inhibitors and acid-related diseases. Pharmacotherapy, 17, 22, 1997.
2. Fujisaki H., Shibata H., Oketani K., et al. Inhibition of acid secretion by E3810 and omeprazole, and their reversal by glutathione. Biochem. Phatmacol., 42, 321, 1991.
3. Tomiyama Y., Morii M., Takeguchi N. Specific proton pump inhibitors E3810 and lansoprazole affect the recovery process of gastric secretion in rats differently. Biochem. Pharmacol., 48, 2049, 1994.
4. Mattsson H., Andersson K., Larsson H. Omeprazole provides protection against experimentally induced gastric mucosal lesions. Eur. J. Pharmacol., 91, 111, 1983.
5. Konturek S.J., Brzozowski T., Radecki T. Protective action of omeprazole, a benzimidazole derivative, on gastric mucosal damage by aspirin and ethanol in rats. Digestion, 27, 159, 1983.
6. Satou H., Inatomi N., Nagaya H., Inada I., Nohara A., Nakamura N., Maki Y. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats. J. Pharmacol. Exp. Ther., 248, 809, 1989.
7. Okabe S., Miyake H., Awaya Y. Cytoprotective effects of NC-1300 and omepazole on HCl-ethanol-induced gastric lesions in rats. Jpn. J. Pharmacol., 42, 123, 1989.
8. Arakawa T., Fukuda T., Higuchi K., Koike K., Satoh H., Kobaysshi K. NC-1300, a proton-pump inhibitor, requires gastric acid to exert cytoprotection in rat gastric mucosa. Jpn. J. Pharmacol., 61, 299, 1993.
9. Whittle B.J.R., Lopez-Belmonte J., Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: Interaction with prostanoids and sensory neuropeptides in the rat. Br. J. Pharmacol., 99, 607, 1990.
10. Whittle B.J.R. Neural and endothelium-deprived mediators in the modulation of the gastric microcirculation: Integrity in the balance. Br. J. Pharmacol., 110, 3, 1993.
11. Robert A., Nezamis J.E., Lancaster C., Hanchar A.J. Cytoprotection by prostaglandins in rats: Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology, 77, 433, 1979.
12. Konturek S.J., Brzozowski T., Majka J., Czarnobilski K. Role of nitric oxide and prostaglandins in sucralfate-induced gastroprotection. Eur. J. Pharmaco., 211, 277, 1992.
13. Arakawa T., Higuchi K., Fujiwara Y., et al. Gastroprotection by Liu-Jun-Zi-Tang (TJ-43): Possible mediation of nitric oxide but not prostaglandins or sulfhydryls. Drugs Exptl. Clin. Res., 25, 207, 1999.
14. Guth P.H., Paulsen G., Nagata H. Histologic and microcirculatory changes in alcohol-induced gastric lesions in the rats: Effect of prostaglandin cytoprotection. Gastroenterology, 87, 1083, 1984.
15. Trier J.S., Szabo S., Allan C.H. Ethanol-induced damage to mucosal capillaries of rat stomach. Gastroenterology, 92, 13, 1987.
16. Masuda E., Kawano S., Nagano K., et al. Endogenous nitric oxide modulates ethanol-induced gastric mucosal injury in rats. Gastroenterology, 108, 58, 1995.